Pankit Vachhani, MD

Pankit Vachhani, MD is an assistant professor of medicine at University of Alabama at Birmingham and associate scientist in experimental therapeutics. He leads the Leukemia/BMT group and focuses on clinical trials in acute myeloid leukemia (AML) and myeloproliferative neoplasms (MPNs). He also serves on NCCN panels for AML and MPN treatment guidelines.

Articles by Pankit Vachhani, MD

Naval Daver, MDChronic Myeloid Leukemia | June 5, 2025
Expert insights from a HemOnc Pulse Live! session offer a compelling look at where CML and MPN care is headed.
View More
Pankit Vachhani, MDMyelofibrosis | May 12, 2025
Experts discuss patient-centered approaches and novel therapies reshaping MF treatment in a roundtable.
Prithviraj Bose, MDMyelofibrosis | May 12, 2025
Experts explore anemia therapies, JAK inhibitors, and transplant innovations shaping the promising future of MF care.
Naseema Gangat, MBBSMyelofibrosis | May 12, 2025
Experts discuss molecular insights into MF, highlighting mutations, risk assessment, and evolving therapeutic approaches.
Prithviraj Bose, MDMyelofibrosis | May 12, 2025
Experts discuss current treatments and ongoing research in myelofibrosis, highlighting new therapies and clinical trials.
Idoroenyi Amanam, MDMyelofibrosis | May 12, 2025
Experts discuss CALR-targeting therapies, symptom assessment, and the future of myelofibrosis treatment and regulation.